Capstone Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.05M Buy
+2,359
New +$1.05M ﹤0.01% 387
2025
Q1
Sell
-7,980
Closed -$3.21M 860
2024
Q4
$3.21M Buy
7,980
+7,110
+817% +$2.86M 0.01% 224
2024
Q3
$405K Buy
+870
New +$405K ﹤0.01% 469
2024
Q2
Sell
-4,359
Closed -$1.82M 1474
2024
Q1
$1.82M Buy
4,359
+3,013
+224% +$1.26M 0.01% 340
2023
Q4
$548K Buy
+1,346
New +$548K ﹤0.01% 483
2023
Q3
Hold
0
1313
2023
Q2
Sell
-3,063
Closed -$965K 976
2023
Q1
$965K Buy
3,063
+2,094
+216% +$660K ﹤0.01% 276
2022
Q4
$280K Buy
+969
New +$280K ﹤0.01% 505
2022
Q3
Sell
-1,193
Closed -$336K 896
2022
Q2
$336K Buy
1,193
+1,192
+119,200% +$336K ﹤0.01% 555
2022
Q1
$0 Sell
1
-12,059
-100% ﹤0.01% 1160
2021
Q4
$2.65M Sell
12,060
-89,256
-88% -$19.6M ﹤0.01% 278
2021
Q3
$18.4M Buy
101,316
+65,894
+186% +$12M 0.04% 85
2021
Q2
$7.14M Buy
35,422
+22,814
+181% +$4.6M 0.02% 112
2021
Q1
$2.71M Sell
12,608
-19,479
-61% -$4.19M 0.01% 157
2020
Q4
$7.58M Buy
+32,087
New +$7.58M 0.03% 76
2020
Q3
Hold
0
610
2020
Q2
Hold
0
574
2020
Q1
Hold
0
550
2019
Q4
Sell
-158
Closed -$27K 593
2019
Q3
$27K Sell
158
-5,224
-97% -$893K ﹤0.01% 333
2019
Q2
$987K Sell
5,382
-565
-10% -$104K 0.01% 236
2019
Q1
$1.09M Buy
5,947
+5,789
+3,664% +$1.06M 0.01% 161
2018
Q4
$26K Sell
158
-1,744
-92% -$287K ﹤0.01% 366
2018
Q3
$367K Buy
+1,902
New +$367K ﹤0.01% 252
2017
Q4
Sell
-2,600
Closed -$395K 557
2017
Q3
$395K Buy
+2,600
New +$395K 0.01% 255
2016
Q4
Sell
-28,284
Closed -$2.47M 905
2016
Q3
$2.47M Buy
+28,284
New +$2.47M 0.05% 153
2016
Q2
Sell
-4,600
Closed -$365K 768
2016
Q1
$365K Buy
+4,600
New +$365K 0.01% 403
2014
Q3
Hold
0
284
2014
Q2
Hold
0
257
2014
Q1
Hold
0
277
2013
Q3
Hold
0
235
2013
Q2
Hold
0
186